BEAM Margin dodolan operasi Beam Therapeutics Inc

Beam Therapeutics Inc. - logo grafis emiten BEAM

Beam Therapeutics Inc. (BEAM) is developing precision therapies in collaboration with Pfizer. The company is currently in the primary clinical trial stage, which is temporarily increasing research expenditures. The competitive advantage of Beam Therapeutics Inc. (BEAM) lies in its patents for safe, site-specific DNA editing. Operating profitability on the GURU.Markets chart reflects the asset's dynamics, where -267.70 indicates the current level.

BEAM: Rentabilitas kegiatan operasi beamtx.com 04.07.2022 - 20.11.2026

BEAM (Beam Therapeutics): rincian analitis lan laporan miturut indikator

Pambiji fundamental perusahaan:Beam Tx, BEAM
Barang utama beamtx.com

To identify the sector's fundamental leaders, the analyst evaluates the operating margin as the ratio of profit from core operations to revenue before taxes and interest. This metric measures cost management efficiency, which in the case of Beam Therapeutics Inc. (BEAM) depends directly on the optimization of certified GMP facilities, reflecting in the operating profitability trajectory the company's ability to scale therapy production without increasing costs.

Analisis pesaing

Margin dodolan operasi TEM|QGEN - Tingkat bathi adhedhasar bathi operasi|Margin operasi IONS|RGEN - Rentabilitas dodolan operasi|Rentabilitas operasi Avidity RNA|Margin operasi CRISPR Therapeutics Corp CRSP|GeneDx Corp - Margin operasi|Ultragenyx Pharma (RARE) - Margin dodolan operasi|SRPT (Sarepta Therapeutics Inc) - Margin dodolan operasi|TWST: Rasio bathi operasi|TXG (10xgenomics.com) - Margin operasi|NTLA (Intellia Therapeutics, Inc.) - Rasio bathi operasi|Rentabilitas operasi Stoke Corp (STOK)|Rentabilitas kegiatan operasi BioLife|Margin operasi WVE (Wave Life Sciences Ltd)|MAZE: Rentabilitas dodolan miturut bathi operasi|Sionna Therapeutics, Inc. - Margin operasi|Tingkat bathi operasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Margin dodolan operasi|QURE - Rentabilitas kegiatan operasi|MGTX (MeiraGTx Corp) - Margin operasi|Rentabilitas dodolan operasi REGENXBIO Inc. RGNX|Rentabilitas operasi Solid Biosciences (SLDB)|Ocugen Corp - Rentabilitas dodolan miturut bathi operasi|Rentabilitas operasi Pacific Biosciences PACB|Rasio bathi operasi BNTC (Benitec)|Design Corp - Margin operasi|Rocket Pharmaceuticals - Rasio bathi operasi|Rentabilitas dodolan miturut bathi operasi 4D Molecular Therapeutics, Inc.|Rentabilitas dodolan operasi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Margin operasi|Rentabilitas dodolan operasi Editas EDIT|Margin operasi SLN|ProQR Therapeutics - Rentabilitas dodolan miturut bathi operasi|Margin operasi CDXS (Codexis, Inc.)|SGMO: Rentabilitas dodolan miturut bathi operasi|Nautilus Biotechnology - Margin operasi|Tingkat bathi operasi MGX (Metagenomi, Inc)|DTIL: Margin operasi|GBIO: Rasio bathi operasi|Rentabilitas operasi Boundless Bio Inc.|Margin dodolan operasi Exicure (XCUR)|Margin operasi IMNN|PHIO (Phio Pharmaceuticals Corp.) - Tingkat bathi operasi|Mustang Bio, Inc. - Margin dodolan operasi|RNAZ - Margin dodolan operasi|BNGO: Margin dodolan operasi|APDN (Applied DNA Sciences Inc) - Rentabilitas dodolan miturut bathi operasi|BLUE (Bluebird Bio) - Margin dodolan operasi|ImmunoPrecise Antibodies Ltd - Tingkat bathi operasi|OMGA (Omega Therapeutics Inc) - Margin operasi|Rentabilitas operasi OMIC|Rentabilitas operasi Regulus Therapeutics Inc. (RGLS)|Margin dodolan operasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Margin dodolan operasi|Tingkat bathi operasi TCON|UBX - Rentabilitas operasi